PATENT CLAIM ANALYSIS

Application Number: 16078409
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "299000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases.

Claim (Index 2):
The method according to  claim 1 , wherein the disease is a chronic liver disease including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), drug-induced bile duct injury, gallstones, liver cirrhosis, alcohol-induced cirrhosis, cystic fibrosis, bile duct obstruction, cholelithiasis, or liver fibrosis.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.03571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16335662', '14909263', '15263033', '16030141', '15139138']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7639156301778532
- 35 USC 102 Novelty (BERT): 0.5092158699119035
- Combined Prediction Score: 0.7384456541512583
- Mean Citation Score: 231.63671
- Max Citation Score: 240.76369
- Similarity Product: 151.93406783066268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test